Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Avanos Medical Inc (NYSE: AVNS) closed the day trading at $12.15 down -4.41% from the previous closing price of $12.71. In other words, the price has decreased by -$4.41 from its previous closing price. On the day, 0.61 million shares were traded. AVNS stock price reached its highest trading level at $12.635 during the session, while it also had its lowest trading level at $12.11.
Ratios:
For a better understanding of AVNS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.79 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.93. For the most recent quarter (mrq), Quick Ratio is recorded 1.56 and its Current Ratio is at 2.57. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.14.
On May 22, 2023, CL King started tracking the stock assigning a Buy rating and target price of $31.
Stephens Downgraded its Overweight to Equal-Weight on August 04, 2021, whereas the target price for the stock was revised from $60 to $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’25 when Holbrook Kerr sold 7,000 shares for $15.25 per share. The transaction valued at 106,778 led to the insider holds 82,047 shares of the business.
Holbrook Kerr bought 7,000 shares of AVNS for $106,780 on Mar 06 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVNS now has a Market Capitalization of 561864576 and an Enterprise Value of 605764352. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.82 while its Price-to-Book (P/B) ratio in mrq is 0.67. Its current Enterprise Value per Revenue stands at 0.879 whereas that against EBITDA is 6.458.
Stock Price History:
The Beta on a monthly basis for AVNS is 1.15, which has changed by -0.40499508 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, AVNS has reached a high of $25.36, while it has fallen to a 52-week low of $11.84. The 50-Day Moving Average of the stock is -9.52%, while the 200-Day Moving Average is calculated to be -33.56%.
Shares Statistics:
Over the past 3-months, AVNS traded about 524.99K shares per day on average, while over the past 10 days, AVNS traded about 554000 shares per day. A total of 46.24M shares are outstanding, with a floating share count of 44.74M. Insiders hold about 3.26% of the company’s shares, while institutions hold 89.79% stake in the company. Shares short for AVNS as of 1745971200 were 1131437 with a Short Ratio of 2.16, compared to 1743379200 on 723475. Therefore, it implies a Short% of Shares Outstanding of 1131437 and a Short% of Float of 3.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
